Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels |
|---|---|---|---|
| 1 | |||
| Dysgeusia | x | ||
| Rash | x | ||
| Eye infection | x | ||
| Eye penetration | x | ||
| Headache | x | ||
| Hypersensitivity | x | ||
| Mydriasis | x | ||
| Pruritus | x | ||
| Urticaria | x | ||
| Nerve injury | x | ||
| Intraocular pressure increased | x | ||
| Eye irritation | x | ||
| Corneal perforation | x | ||
| Vision blurred | x | ||
| Visual disturbance | x | ||
| Posterior subcapsular cataract | x | ||
| Corneal thinning | x | ||
Information about indications was extracted from the indications and usage sections of the labels.
| Indication | Labels | ||
|---|---|---|---|
| Inflammation | x | ||
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |